Company: TDY
Filing Date: 2025-02-28
Form Type: PRE 14A
Source: 0001193125-25-042748
Chunk: 93

Company: TELEDYNE TECHNOLOGIES INC
Filing Date: 2025-02-28
Form: PRE 14A
Chunk 93
---
 was retirement eligible on December 29, 2024. |

| TELEDYNE TECHNOLOGIES INCORPORATED | 2025 Proxy Statement |     | 81 |

Potential Payments Upon Termination or a Change in Control (continued)

| (2) | Represents the 2024 AIP award at target. |

| (3) | Represents the number of all unvested stock options as of December 29, 2024, multiplied by $471.44, the closing price of our common stock on December 27, 2024, the last trading day prior to our fiscal year end, less the aggregate exercise price of the unvested stock options. |

| (4) | Assumes that unvested stock options are assumed or replaced by acquirer or otherwise remain outstanding. |

| (5) | Represents the number of all unvested stock options as of December 29, 2024, multiplied by $471.44, the closing price of our common stock on December 27, 2024, less the aggregate exercise price of the unvested stock options. Option awards accelerate in full upon death and continue vesting following disability. |

| (6) | Represents the number of unvested shares of restricted stock and restricted stock units granted in 2022, 2023 and 2024 multiplied by $471.44, the closing price of our common stock on December 27, 2024. |

| (7) | Represents the present value of unvested restricted stock granted in 2022, 2023 and 2024 pro-rated for the portion of the performance period completed by the named executive prior to retirement, termination, death or disability. Assumes goals are met at 100% of performance targets. Actual payment of the stock award is not made until after the completion of the performance period. Shares are valued at $471.44, the closing price of our common stock on December 27, 2024. |

| (8) | Represents the cash payable under our 2023-2025 Performance Plan award and our 2024-2026 Performance Plan award, assuming applicable goals are met at the maximum (200%) performance target for all named executives other than Dr. Roks (for whom applicable goals are assumed met at 100% of performance target). |

| (9) | Represents the cash payable under our 2023-2025 Performance Plan award and 2024-2026 Performance Plan award,